2016 International Congress Archives - Page 15 of 207

12:00pm-1:30pm: Detecting brainstem changes in Parkinson’s disease using quantitative MRI

C. Lambert, A. Lutti, B. Draganski, T. Foltynie (London, United Kingdom)

Parkinson's disease: Neuroimaging and neurophysiology · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Detection of primary olfactory cortex dysfunction in early-stage Parkinson’s disease

J. Wang, T. Subramanian, Q.X. Yang (Hershey, PA, USA)

Parkinson's disease: Neuroimaging and neurophysiology · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Development of a tool for assessment of embarrassment due to dystonia

R. Verma, K.S. Anand (New Delhi, India)

Rating scales · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Developmental movement patterns resemble movement disorder features in healthy babies and toddlers

M.J. Kuiper, R. Brandsma, R.J. Lunsing, H. Eggink, H. Burger, H.J. Ter Horst, A.F. Bos, D.A. Sival (Groningen, Netherlands)

Phenomenology and clinical assessment of movement disorders · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Diagnosis and management of dementia with Lewy bodies: Influence of concomitant cerebrovascular disease

A. Chimagomedova, E. Vasenina, O. Levin (Moscow, Russia)

Cognitive disorders · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Diagnostic accuracy of common bedside ataxia examination tests

R. Thompson, P. Woolman, D.E. Bhatti, A. Hellman, J.M. Bertoni, D. Torres-Russotto (Omaha, NE, USA)

Phenomenology and clinical assessment of movement disorders · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Diagnostic performance of the Spanish version of the 19-items wearing-off questionnaire in Mexican patients with PD

D. Cruz-Fino, A. Alvarado-Bolaños, M. Rodríguez-Violante, A. Cervantes-Arriaga (Mexico City, Mexico)

Rating scales · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Diagnostic reliability of clinical symptoms in patients with incomplete manifestation of the triad of parkinsonism compared to 18F-DOPA PET-CT MRI imaging

C. Peralta, T. Soto Depetris, A. Perez, F. Biafore, J. Gili, A. Valda, D. Menna, M. Aguilar, H. Corradini, M. Bastianello (Caba, Argentina)

Parkinson's disease: Neuroimaging and neurophysiology · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Differences in MDS-UPDRS scores based on Hoehn and Yahr stage and disease duration: Results of a large international multicenter study of 3206 patients (the QUALPD study)

M. Skorvanek, P. Martinez-Martin, N. Kovacs, I. Zezula, M. Rodriguez-Violante, J.C. Corvol, P. Taba, K. Seppi, O. Levin, A. Schrag, T. Foltynie, M. Alvarez-Sanchez, T. Arakaki, Z. Aschermann, I. Aviles-Olmos, E. Benchetrit, C. Benoit, A. Bergareche-Yarza, A. Cervantes-Arriaga, A. Chade, F. Cormier, V. Datieva, D.A. Gallagher, N. Garretto, Z. Gdovinova, O. Gershanik, M. Grofik, V. Han, J. Huang, L. Kadastik-Eerme, M.M. Kurtis, G. Mangone, J.C. Martinez-Castrillo, A. Mendoza-Rodriguez, M. Minar, H.P. Moore, M. Muldmaa, C. Mueller, B. Pinter, W. Poewe, K. Rallmann, E. Reiter, C. Rodriguez-Blazquez, C. Singer, B.C. Tilley, P. Valkovic, C.G. Goetz, G.T. Stebbins (Kosice, Slovakia (Slovak Republic))

Rating scales · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Diffusion tensor imaging in Parkinson’s disease: Review and meta-analysis with clinical considerations and neuroimaring parameters

C. Atkinson-Clement, S. Pinto, A. Eusebio, O. Coulon (Aix-en-Provence, France)

Parkinson's disease: Neuroimaging and neurophysiology · Exhibit Hall located in Hall B, Level 2